Company Directory - Intellia Therapeutics Inc.
Company Details - Intellia Therapeutics Inc.
Intellia Therapeutics Inc.
WebsiteCambridge, United States
ISIN: US45805T1094
Intellia Therapeutics is a biotechnology company dedicated to developing curative therapies using CRISPR gene editing technology.
CCI Score
CCI Score: Intellia Therapeutics Inc.
-13.08
0.02%
Latest Event
Intellia Therapeutics Lobbying Spending 2021
Intellia Therapeutics spent $120,000 on lobbying in 2021. This expenditure raises concerns about corporate influence on political processes that can undermine democratic accountability and potentially enable authoritarian practices.
Take Action
So what can you do? It's time to make tough choices. Where will you cast your vote?
- Shop Alternatives
SEE ALL - Use Your Voice
OTHER TOOLS - Investigate
- Share the Score
SUPPORT CCI
ENABLER
Intellia Therapeutics Inc. is currently rated as an Enabler.
Latest Events
- DEC312021
Intellia Therapeutics spent $120,000 on lobbying in 2021. This expenditure raises concerns about corporate influence on political processes that can undermine democratic accountability and potentially enable authoritarian practices.
-20
Political Contributions and Lobbying Efforts
March 21
The spending of $120,000 on lobbying by Intellia Therapeutics indicates an engagement in political influence practices. From an anti-fascist perspective, such lobbying activities are problematic as they can contribute to regulatory capture and the subversion of democratic processes. Although the amount is moderate, it still signals a willingness to influence policy in favor of corporate interests, which raises concerns about complicity in supporting conditions that may benefit authoritarian regimes.
- DEC312019
In 2019, Intellia Therapeutics spent $115,000 on lobbying, an action that raises concerns about corporate efforts to influence democratic processes and potentially support authoritarian policymaking.
-20
Political Contributions and Lobbying Efforts
March 21
Intellia Therapeutics' lobbying expenditure of $115,000 in 2019 is viewed as part of a broader pattern of corporate political intervention. From an anti-fascist perspective, such investments in lobbying can be interpreted as attempts to shape policy in ways that favor corporate interests over public welfare and democratic accountability.
Alternatives
Zug, Switzerland
22.95
Corporation
0.00
_0.png?VersionId=E54j6B2ssY0mos4wxJcXCOh7Hall1IAR)
New York, United States
-1.65
Beijing, China
0.00
Corporation
27.23
Corporation
9.63
Corporation
0.00
Corporation
0.00
Corporation
0.00
Corporation
0.00
Industries
- 325414
- Biological Product (except Diagnostic) Manufacturing
- 541714
- Research and Development in Biotechnology (except Nanobiotechnology)
- 621511
- Medical Laboratories